Logo

Colorectal Cancer

News and reporting on colorectal cancer.

Guardant Health, Ohio State University Partner on Blood-Based Colon Cancer Screening Study

OSU investigators will offer the Guardant Shield assay to patients via mobile phlebotomists, studying adoption rates among approximately 300 individuals.

Mainz Biomed Partners With Labor Staber to Market ColoAlert Test

Labor Staber will market the colorectal cancer screening kit through its network of physicians and laboratories in Germany.

Neogap Therapeutics, Simsen Diagnostics Collaborate on Cancer Dx

The companies will examine circulating tumor DNA in blood samples from patients participating in Neogap's Phase I/II clinical trial. 

Guardant Health Submits Colorectal Cancer Screening Test to FDA for Premarket Approval

The firm's application is supported by data from the ECLIPSE study, which compared results of the Shield test to colonoscopy findings in 20,000 individuals.

Biocartis Nabs FDA 510(k) Clearance for Lynch Syndrome Screening Assay

The Idylla MSI Test identifies microsatellite instability in colorectal cancer tumors to aid in the identification of potential Lynch syndrome.

Feb 24, 2023

Guardant Health Confident in 2023 Growth Despite Lower-Than-Expected Revenue Guidance
Premium

Feb 22, 2023

Exact Sciences Q4 Revenues up 17 Percent as Firm Preps Expanded Oncology Portfolio in 2023
Premium

Feb 21, 2023

Mainz Biomed Acquires Colorectal Cancer Testing IP From Uni Targeting Research, Socpra Sciences

Feb 15, 2023

Guardant Health to Study Impact of Shield Blood Test on Colorectal Cancer Screening Compliance

Feb 15, 2023

Epigenomics Announces Layoffs, Product Line Cancellation in Restructuring

Feb 15, 2023

Mainz Biomed Inks Commercialization Deals for Colorectal Cancer Test in UK, Spain

Feb 2, 2023

Universal DX Eyeing Approval for Colorectal Cancer Early Detection Test After Positive Data
Premium

Jan 26, 2023

NY Genome Center Team Harnesses Ultima Genomics Platform for High-Sensitivity ctDNA Sequencing
Premium

Jan 24, 2023

New Study Results Boost Evidence for Natera's MRD Assays to Guide Adjuvant Therapy Decisions
Premium

Jan 24, 2023

Geneoscopy Submits PMA Application to FDA for Stool-Based Colorectal Cancer Screening Test

Jan 19, 2023

Colorectal Cancer Detection Data from CellMax Life Bodes Well for Planned FDA Bid
Premium

Jan 19, 2023

Guardant Health, Royal Marsden Partner on Prospective Liquid Biopsy Trial in Early Colorectal Cancer

Jan 17, 2023

Blu Biotech Sniffing Out Infections, Cancer With Multi-Disease Breathalyzer
Premium

Jan 9, 2023

Guardant Health Preliminary Q4 Revenues Grow 15 Percent to 17 Percent

Dec 22, 2022

Colorectal Cancer Lines Characterized With Top-Down Proteomics Approaches

Dec 20, 2022

Multiomic Study Points to New Colorectal Cancer Risk Contributors

Dec 16, 2022

Guardant Health CRC Screening Results Spook Investors Despite Meeting Reimbursement Requirements

Dec 6, 2022

Mainz Biomed to Initiate Pivotal US Clinical Study for Colorectal Cancer Early Detection Test

Nov 30, 2022

Personalis, UCSF to Study ctDNA Utility in Colorectal Cancer Treatment Response Monitoring

Oct 26, 2022

Genetic, Epigenetic Factors Alongside Phenotypic Plasticity Influence Colorectal Cancer Evolution

Breaking News
The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to qualitative interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.